These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15789356

  • 1. Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85.
    Boggiano C, Moya R, Pinilla C, Bihl F, Brander C, Sidney J, Sette A, Blondelle SE.
    Eur J Immunol; 2005 May; 35(5):1428-37. PubMed ID: 15789356
    [Abstract] [Full Text] [Related]

  • 2. Immunogenically optimized peptides derived from natural mutants of HIV CTL epitopes and peptide combinatorial libraries.
    Blondelle SE, Moya-Castro R, Osawa K, Schroder K, Wilson DB.
    Biopolymers; 2008 May; 90(5):683-94. PubMed ID: 18481808
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R.
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [Abstract] [Full Text] [Related]

  • 4. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 5. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.
    J Immunol; 2004 Aug 01; 173(3):2126-33. PubMed ID: 15265949
    [Abstract] [Full Text] [Related]

  • 6. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 7. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M.
    J Immunol; 2004 May 01; 172(9):5249-61. PubMed ID: 15100263
    [Abstract] [Full Text] [Related]

  • 8. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ, Dubey SA, Anderson K, Baan E, Bakker M, Pollakis G, Paxton WA, Shiver JW, Goudsmit J.
    J Virol; 2005 Sep 01; 79(17):11247-58. PubMed ID: 16103177
    [Abstract] [Full Text] [Related]

  • 9. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM, Lewinsohn DA, Riddell SR, Greenberg PD, Mosier DE.
    J Immunol; 1999 Jul 15; 163(2):861-7. PubMed ID: 10395680
    [Abstract] [Full Text] [Related]

  • 10. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Jul 15; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 11. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J, Bajcz M, Schaubert KL, Price DA, Brenchley JM, Asher TE, Douek DC, Ng HL, Yang OO, Rinaldo CR, Benito JM, Bisikirska B, Hegde R, Marincola FM, Boggiano C, Wilson D, Abrams J, Blondelle SE, Wilson DB.
    J Immunol; 2006 Jun 01; 176(11):6690-701. PubMed ID: 16709828
    [Abstract] [Full Text] [Related]

  • 12. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M, Tang S, Therrien D, Kløverpris H, Vinner L, Kronborg G, Gerstoft J, Corbet S, Fomsgaard A.
    APMIS; 2007 Jun 01; 115(6):757-68. PubMed ID: 17550385
    [Abstract] [Full Text] [Related]

  • 13. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
    Buseyne F, Chaix ML, Rouzioux C, Blanche S, Rivière Y.
    J Virol; 2001 May 01; 75(10):4941-6. PubMed ID: 11312369
    [Abstract] [Full Text] [Related]

  • 14. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M, Soriano V, Lozano S, Martinez P, Sempere J, González-Lahoz J, Benito J.
    AIDS Res Hum Retroviruses; 2006 Sep 01; 22(9):884-92. PubMed ID: 16989614
    [Abstract] [Full Text] [Related]

  • 15. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD.
    J Virol; 1999 Dec 01; 73(12):10191-8. PubMed ID: 10559335
    [Abstract] [Full Text] [Related]

  • 16. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C, Goulder PJ, Luzuriaga K, Yang OO, Hartman KE, Jones NG, Walker BD, Kalams SA.
    J Immunol; 1999 Apr 15; 162(8):4796-800. PubMed ID: 10202022
    [Abstract] [Full Text] [Related]

  • 17. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S, Marini E, Bozzo L, Trainini L, Saadoune L, Avolio M, Pontillo A, Bonfanti C, Sarmientos P, Caruso A.
    Biopolymers; 2004 Apr 15; 76(4):334-43. PubMed ID: 15386266
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 15; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

  • 19. Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.
    Hückelhoven AG, Etschel JK, Bergmann S, Zitzelsberger K, Mueller-Schmucker SM, Harrer EG, Harrer T.
    J Acquir Immune Defic Syndr; 2015 Aug 15; 69(5):528-35. PubMed ID: 25900164
    [Abstract] [Full Text] [Related]

  • 20. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H, Wakabayashi A, Shimizu M, Kaneko H, Norose Y, Nakagawa Y, Wang J, Kumagai Y, Margulies DH, Takahashi H.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):356-63. PubMed ID: 15020225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.